had covid/ pneumonia; upper respiratory infection; Lack of drug effect; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 PNEUMONIA (had covid/ pneumonia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DRUG INEFFECTIVE (Lack of drug effect). On an unknown date, the patient experienced COVID-19 PNEUMONIA (had covid/ pneumonia) (seriousness criterion medically significant) and UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection). The patient was treated with PREDNISONE for Adverse event, at a dose of 50 milligram. At the time of the report, COVID-19 PNEUMONIA (had covid/ pneumonia), UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.            Treatment medication include: monoclonal antibodies, antibiotic.  Reported that Patient had monoclonal antibodies, it wasn't the infusion but needles in her abdomen. She has asthma. She was very sick with covid. Took Prednisone 12 days out of 14, it was very bad with her asthma. She took an antibiotic because after 50mg of prednisone for 5 days, 2 days later she was back at the urgent care center. She had started pneumonia, upper respiratory infection. She is going to take another X-ray to see if she had damage to her lungs.  Company comment:  This spontaneous case of drug ineffective concerns a female  patient with relevant medical history of asthma, who experienced serious unexpected event of COVID-19 pneumonia. The event occurred approximately 7.5 months after the 2nd dose of the mRNA-1273 . Reportedly, the patient was very sick and received unspecified monoclonal antibodies, unspecified antibiotics and prednisone as a corrective treatment for the event. The rechallenge was not applicable since due to occurrence after the second dose and nature of the event, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-421482 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Dec-2021: Follow-up received and does not contain any new information; Sender's Comments: This spontaneous case of drug ineffective concerns a female  patient with relevant medical history of asthma, who experienced serious unexpected event of COVID-19 pneumonia. The event occurred approximately 7.5 months after the 2nd dose of the mRNA-1273 . Reportedly, the patient was very sick and received unspecified monoclonal antibodies, unspecified antibiotics and prednisone as a corrective treatment for the event. The rechallenge was not applicable since due to occurrence after the second dose and nature of the event, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of mRNA-1273 is not affected by this report.